You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR CLOZARIL

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for CLOZARIL

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00042224 ↗	Electroconvulsive Therapy in Clozapine Refractory Schizophrenia	Completed	National Institute of Mental Health (NIMH)	Phase 1/Phase 2	2000-12-01	This study will evaluate electroconvulsive therapy (ECT) in patients who have not responded adequately to clozapine.
NCT00042224 ↗	Electroconvulsive Therapy in Clozapine Refractory Schizophrenia	Completed	Northwell Health	Phase 1/Phase 2	2000-12-01	This study will evaluate electroconvulsive therapy (ECT) in patients who have not responded adequately to clozapine.
NCT00154258 ↗	A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia	Completed	Novartis	Phase 2	2001-04-01	Clozapine is an antipsychotic. This open study will evaluate the safety and efficacy of long term treatment of clozapine in patients with treatment-resistant schizophrenia.
NCT00169091 ↗	Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia	Terminated	Commonwealth Research Center, Massachusetts	Phase 4	1996-03-01	This study will examine the physical responses brought on by clozapine and haloperidol in people experiencing their first episode of schizophrenia.
NCT00169091 ↗	Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia	Terminated	Dartmouth-Hitchcock Medical Center	Phase 4	1996-03-01	This study will examine the physical responses brought on by clozapine and haloperidol in people experiencing their first episode of schizophrenia.
NCT00169091 ↗	Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia	Terminated	National Institute of Mental Health (NIMH)	Phase 4	1996-03-01	This study will examine the physical responses brought on by clozapine and haloperidol in people experiencing their first episode of schizophrenia.
NCT00169091 ↗	Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia	Terminated	Novartis	Phase 4	1996-03-01	This study will examine the physical responses brought on by clozapine and haloperidol in people experiencing their first episode of schizophrenia.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for CLOZARIL

Condition Name

Chart
Table

Condition Name for CLOZARIL
Intervention	Trials
Schizophrenia	18
Schizoaffective Disorder	8
Bipolar Disorder	2
Psychotic Disorders	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for CLOZARIL
Intervention	Trials
Schizophrenia	19
Psychotic Disorders	10
Disease	6
Bipolar Disorder	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for CLOZARIL

Trials by Country

Map
Table

Trials by Country for CLOZARIL
Location	Trials
United States	23
Canada	4
Korea, Republic of	3
Japan	1
Brazil	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for CLOZARIL
Location	Trials
New Hampshire	3
California	3
Massachusetts	3
New York	3
South Carolina	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for CLOZARIL

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for CLOZARIL
Clinical Trial Phase	Trials
Phase 4	11
Phase 3	1
Phase 2	2
[disabled in preview]	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for CLOZARIL
Clinical Trial Phase	Trials
Completed	12
Recruiting	3
Unknown status	2
[disabled in preview]	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for CLOZARIL

Sponsor Name

Chart
Table

Sponsor Name for CLOZARIL
Sponsor	Trials
National Institute of Mental Health (NIMH)	5
Dartmouth-Hitchcock Medical Center	4
Centre for Addiction and Mental Health	3
[disabled in preview]	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for CLOZARIL
Sponsor	Trials
Other	41
Industry	7
NIH	6
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.